Solvay has sold its facility in Charleston, SC, and the phosphorus derivatives-based products made at the plant, to Lanxess

Lincoln International, a leading global mid-market investment bank, is pleased to announce that it has represented Solvay SA (EBR:SOLB; “Solvay”) in the sale of its Charleston, South Carolina facility, and the associated phosphorus derivatives-based products made at the plant, to Lanxess AG (ETR:LXS), a specialty chemicals company headquartered in Germany.

Lincoln International acted as the exclusive financial advisor to Solvay, working closely with shareholders and management throughout the sale process. This included providing advisory expertise and managing the various phases of the transaction.

About Solvay SA

Solvay is a multi-specialty chemical company, committed to developing chemistry that addresses key societal challenges. Solvay innovates and partners with customers in diverse global end markets. Its products and solutions are used in planes, cars, smart and medical devices, batteries, in mineral and oil extraction, among many other applications promoting sustainability. Its lightweighting materials enhance cleaner mobility, its formulations optimize the use of resources and its performance chemicals improve air and water quality. Solvay is headquartered in Brussels with around 27,000 employees in 58 countries. More information about Solvay can be obtained at www.solvay.com.

Solvay has sold its facility in Charleston, SC, and the phosphorus derivatives-based products made at the plant, to Lanxess
  • 2018
    Close Year
  • Chemicals | Industrials
    Industry
  • Public
    Client Type
  • Strategic | Cross-border
    Transaction Type
  • Belgium | USA | Germany
    Countries

Meet our Senior Team